| Jan 15, 2025 |
Jan 16, 2025 |
VYNE Therapeutics Inc.
|
Director |
Buy |
91.3
|
+15,000
|
41.13%
|
✗
|
$43.8K |
| Nov 15, 2023 |
Nov 17, 2023 |
VYNE Therapeutics Inc.
|
Director |
Buy |
95.0
|
+13,000
|
55.39%
|
✗
|
$50.8K |
| Mar 20, 2023 |
Mar 22, 2023 |
VYNE Therapeutics Inc.
|
Director |
Buy |
91.3
|
+20,000
|
576.04%
|
✗
|
$49.7K |
| Nov 30, 2021 |
Dec 2, 2021 |
VYNE Therapeutics Inc.
|
Director |
Buy |
91.3
|
+12,500
|
25.00%
|
✓
|
$12.7K |
| Aug 25, 2021 |
Aug 26, 2021 |
VYNE Therapeutics Inc.
|
Director |
Buy |
91.3
|
+12,500
|
33.33%
|
✗
|
$20K |
| May 26, 2021 |
May 27, 2021 |
VYNE Therapeutics Inc.
|
Director |
Buy |
91.3
|
+12,500
|
50.00%
|
✗
|
$45K |
| Mar 15, 2021 |
Mar 16, 2021 |
VYNE Therapeutics Inc.
|
Director |
Buy |
95.0
|
+12,500
|
100.00%
|
✗
|
$92.6K |
| Dec 3, 2020 |
Dec 7, 2020 |
VYNE Therapeutics Inc.
|
Director |
Buy |
95.0
|
+50,000
|
100.00%
|
✓
|
$85.4K |
| May 14, 2020 |
May 18, 2020 |
Matinas BioPharma Holdings, Inc.
|
Director |
Buy |
95.0
|
+100,000
|
33.33%
|
✗
|
$73.1K |
| Nov 15, 2019 |
Nov 19, 2019 |
Matinas BioPharma Holdings, Inc.
|
Director |
Buy |
95.0
|
+100,000
|
50.00%
|
✗
|
$105.5K |
| Aug 16, 2019 |
Aug 20, 2019 |
Matinas BioPharma Holdings, Inc.
|
Director |
Buy |
95.0
|
+100,000
|
100.00%
|
✗
|
$71.9K |
| May 16, 2019 |
May 20, 2019 |
Matinas BioPharma Holdings, Inc.
|
Director |
Buy |
95.0
|
+100,000
|
100.00%
|
✗
|
$95.3K |